Author(s): Divyani R. Patil, Divyashree K. Patil, Sunila A. Patil

Email(s): patildivyani7779@gmail.com

DOI: 10.52711/2321-5836.2024.00021   

Address: Divyani R. Patil*, Divyashree K. Patil, Sunila A. Patil
P.S.G.V.P. M’s College of Pharmacy, Shahada.
*Corresponding Author

Published In:   Volume - 16,      Issue - 2,     Year - 2024


ABSTRACT:
The recent advancement in pharmaceutical quality, known as "quality by design" or "QbD," is crucial. Every regulatory authority for pharmaceutical products has placed a high priority on quality. In terms of services, goods, and procedures, quality means client satisfaction. All pharmaceutical items can be made with higher quality by using QbD. This essay discusses the use of Quality by Design (QbD) in the pharmaceutical industry and how it may be used to guarantee the accuracy of pharmaceutical analyses. It's critical to recognise your desired product performance report within this notion of being throughout product design and growth. the quality target product profile (QTPP), the target product profile (TPP), and the identification of essential quality attributes (CQA). Understanding the effects of critical process parameters (CPP), critical material attributes (CAM), and raw material.


Cite this article:
Divyani R. Patil, Divyashree K. Patil, Sunila A. Patil. A Review on Quality by Design. Research Journal of Pharmacology and Pharmacodynamics. 2024;16(2):119-2. doi: 10.52711/2321-5836.2024.00021

Cite(Electronic):
Divyani R. Patil, Divyashree K. Patil, Sunila A. Patil. A Review on Quality by Design. Research Journal of Pharmacology and Pharmacodynamics. 2024;16(2):119-2. doi: 10.52711/2321-5836.2024.00021   Available on: https://rjppd.org/AbstractView.aspx?PID=2024-16-2-10


REFERENCES:
1.    Nadpara NP, Thumar R V, Kalola VN, Patel PB. Review Article Quality By Design (Qbd): A Complete Review. 2012; 17(2): 20–8.
2.    Woodcock J. The concept of pharmaceutical quality American Pharmaceutical Review. 2004; 7(6): 10–5.
3.    Chavan SD, Pimpodkar N V, Kadam AS, Gaikwad PS, Pharm PD. Research and Reviews: Journal of Pharmaceutical Quality Assurance Quality by Design. 2015; 1(2): 18–24.
4.    Woodcock J. The concept of pharmaceutical quality American Pharmaceutical Review. 2004; 7(6): 10–5.
5.    Mimansha Patel: Review article: Quality by Design (QbD). Indo American Journal of Pharmaceutical Research. 2018; 8(11): 1357-60.
6.    Satish K. Mandlik. Iimplementation of Quality by Design (QBD) approach in formulation and Development of Ritonavir Pellets using Extrusion Spheronization method. International J of Applied Pharma. 2020; 12(1): 139 –146.
7.    FDA Guidance for Industry and Review Staff: Target Product Profile – A Strategic Development Process Tool (Draft Guidance).
8.    Roy S. Quality by Design-Holistic concept of concept of building quality in pharmaceuticals. Int. J Pham Biomed Res. 2012; 3:100-108.
9.    Woodcock J. The concept of pharmaceutical quality. American Pharmaceutical Review. 2004; 7(6): 10–5.
10.    Roy S. Quality by Design-Holistic concept of concept of building quality in pharmaceuticals. Int. J Pham Biomed Res. 2012; 3: 100-108.
11.    Q9: Quality Risk Management. ICH Harmonized Tripartite Guidelines. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2006.
12.    Lionberger RA, Lee LS, Lee L, Raw A, Yu LX. Quality by design: Concepts for ANDAs. The AAPS Journal. 2008; 10: 268–276.
13.    Mayur Ashok Chordiya, Hemant Hiraman Gangurde and Vikram Nirmal Sancheti. Quality by design: A Roadmap for quality pharmaceutical products. Journal of Reports in Pharmaceutical Science. 2019; 8(2): 289-94.
14.    Jain S. Quality by Design (QbD): A comprehensive understanding of implementation and challenges in pharmaceutical development. Indian Journal of Pharmaceutical Sciences. 2013; 6: 29-35.
15.    Satish K. Mandlik. Iimplementation of Quality by Design (QBD) approach in formulation and Development of Ritonavir Pellets using Extrusion Spheronization method. International J of Applied Pharma. 2020; 12(1): 139 –146.
16.    Dra Kulich. A Critical Challenges to implementing QbD: AQ&A with FDA. Pharm Technol. 2009; 33: 90-4.
17.    Q9: Quality Risk Management. ICH Harmonized Tripartite Guidelines. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2006.
18.    Q10: Pharmaceutical Quality System, ICH Tripartite Guidelines. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2007

Recomonded Articles:

Author(s): Sachin Aglawe, Amol Gayke, Kavita Sharma, Sonali Jadhav, Sanjivani Gore, Bhagyashri Pandit, Sonali Valate, Mayuri Wagh

DOI: 10.5958/2321-5836.2020.00003.8         Access: Open Access Read More

Author(s): Sanjib Kumar Das, Anuradha Das, Banamali Das, Purnendu Panda, G. C. Bhuyan, Bipin Bihari Khuntia

DOI: 10.5958/2321-5836.2017.00036.2         Access: Open Access Read More

Author(s): Rohit J. Bhor, Harshala Damdhar, Geeta Kokate, Maduri Salve, Swati Andhale

DOI: 10.5958/2321-5836.2016.00025.2         Access: Open Access Read More

Author(s): Purnendu Panda, Banamali Das, DS Sahu, SK Meher, Bikartana Das, GC Bhuyan, Abhijit Joshi MM Rao.

DOI: 10.5958/2321-5836.2015.00027.0         Access: Open Access Read More

Author(s): Serene Adak, Dipesh Chakraborty, Himangshu S. Maji, Satakshi Basu, Pradip Roy, Sutanuka Mitra, Nabanita Mukherjee, Samarendra Barik, Arunava Goswami

DOI: 10.5958/2321-5836.2018.00009.5         Access: Open Access Read More

Author(s): MA Halkai, Arun Patil, MD Akhil Ahmed, AK Beknal .

DOI: 10.5958/2321-5836.2016.00004.5         Access: Open Access Read More

Author(s): Gharge Deepali, Bavaskar Sunil, Todkar Pavan,Dhabale Pandurang.

DOI: Not Available         Access: Open Access Read More

Author(s): Mamillapalli Vani, Mannem Vijaya Sai Sri, Padma Latha Khantamneni

DOI: 10.5958/2321-5836.2018.00014.9         Access: Open Access Read More

Author(s): Banashree Jena, G.C. Nanda, Bipin Bihari Khuntia

DOI: 10.5958/2321-5836.2018.00030.7         Access: Open Access Read More

Author(s): Nishant. M. Patel, H. P. Suryawanshi, S. P. Pawar

DOI: 10.5958/2321-5836.2019.00017.X         Access: Open Access Read More

Author(s): K. B. Mahapatra, A. K. Das, Manjusri Sahoo

DOI: 10.5958/2321-5836.2018.00021.6         Access: Open Access Read More

Author(s): Shivakumar SI, Amreen Begum, Syeda Sana, Ansari Firdous

DOI: Not Available         Access: Open Access Read More

Author(s): Shubhashree MN, Shanta TR, Rinky Thakur, Rama RaoV

DOI: 10.5958/2321-5836.2020.00022.1         Access: Open Access Read More

Author(s): Shraddha P. Amrutkar, Paresh A. Patil, Rajshri S. Patel

DOI: 10.5958/2321-5836.2020.00025.7         Access: Open Access Read More

Author(s): Thejeswar EP, MS Thenmozhi.

DOI: 10.5958/2321-5836.2015.00016.6         Access: Open Access Read More

Author(s): Patil SM, Sapkale GN, Kumbhar PB, Maske AP.

DOI: Not Available         Access: Open Access Read More


Recent Articles




Tags